David Ludwig (Harvard, Boston Childrens Hospital) and journalist Gary Taubes explore the science behind GLP-1s, their impact on insulin, weight loss, and chronic disease, and where dietary strategies like low carb or ketogenic therapy fit in
Useful Resources: Concentration Calculator | Research Use Disclaimer
Lancet Reg Health Eur 29:100617 OHara DV, Janse RJ, Fu EL, Jardine MJ, Carrero J-J (2024) Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care
However, results can vary based on individual factors and adherence to a healthy lifestyle
Additionally, dulaglutide is not suitable for individuals with certain medical conditions, such as severe gastrointestinal disorders